On April 1, Jehoshaphat Research issued a report alleging issues at Doximity, Inc. Jehoshaphat “believe[s] Doximity’s underlying sales, contrary to the Street’s expectations for double-digit growth, are declining at a negative -3-6% rate, but that this decline has been masked through accelerated revenue recognition.” Shares of Doximity, Inc. dropped more than 4% in intraday trading on April 1, 2024.
Contact our attorneys for a no-cost case evaluation.